Foley Partner Louis Lehot Quoted in Law360 Discussing FTC, DOJ Overhaul of Merger Guidelines
18 January 2022
Foley & Lardner LLP Partner Louis Lehot was recently quoted in the Law360 article, “DOJ, FTC Want to Overhaul Merger Guidelines.” Lehot commented to Law360 that he saw in the proposed questions government efforts to expand the purview of deals reviewed and to deepen reviews of both vertical and horizontal deals. The enforcers, Lehot said, also appear keen to “lower the concentration thresholds that would establish a presumption of competitive harm” and look at more non-price factors that could be affected.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”